FILING ANALYSIS · TUESDAY, NOVEMBER 3
Strata Critical Medical, Inc. SRTA — 8-K: Results of Operations and Financial Condition
positive
Strata Critical Medical reported a 50.3% year-over-year revenue increase to $74.1 million in Q3 2026, with adjusted EBITDA of $9.6 million and a $20 million share repurchase authorization, indicating a strong quarterly performance.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →